With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
In this webinar, a panel of experts discuss how technology has aided Life Sciences leaders as they engage with experts at various stages of the product life cycle.
2023 brings increased expectations from the FDA for patient-focused drug development (PFDD). Medical Affairs organizations need to develop new skills to put the patient voice at the center of drug, device, and diagnostic development and evaluation.
This webinar highlights the continued importance of omnichannel engagement for healthcare practitioners and learners and the need to equip our internal teams appropriately.
MAPS speaks with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition, the CEOs of Discreedly and Inphronesis.
This webinar program will focus on the theme of innovation and scientific engagement in Medical Communications, providing a detailed example of how a hackathon event is a valuable approach to enhance idea generation for a defined challenge and presents the opportunity to develop innovative “out-of-the box” solutions as a primary outcome of the event.
In today’s episode, we’re talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment.
In this episode, we’re talking about publications impact with Mike Taylor, Head of Data Insights and Grainne Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science.
A panel of experts will discuss what they have learnt from the last 2 years to take forward to future congress offerings, while also exploring what HCPs want when joining congresses both virtually or face-to-face.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.